The reported statements, read against the company's own industry.
What stands out
Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
5.22BCNY
774.60M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
897.91MCNY
133.16M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-18.69%
Updated Aug 19, 2026
Beta
0.2570x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-67.18%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
5.22BCNY
774.60M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
5.10BCNY
756.20M · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
20.88x
Updated Aug 19, 2026
Price to Sales (TTM)
5.93x
Updated Aug 19, 2026
Price to Book (MRQ)
3.34x
Updated Aug 19, 2026
Enterprise to Revenue
5.68x
Updated Aug 19, 2026
Enterprise to EBITDA
-39.60x
Updated Aug 19, 2026
Gross Margin
14.95%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 19.76%.Updated Aug 19, 2026
Profit Margin
-18.69%
Updated Aug 19, 2026
Operating Margin
-32.22%
Updated Aug 19, 2026
Return on Assets (TTM)
-4.86%
Updated Aug 19, 2026
Return on Equity (TTM)
-10.02%
Updated Aug 19, 2026
Revenue (TTM)
897.91MCNY
133.16M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
2.64CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
48.90%
Updated Aug 19, 2026
Gross Profit (TTM)
177.46MCNY
26.32M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
-128.76MCNY
-19.10M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-167.80MCNY
-24.88M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
48.89%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
-228.72MCNY
-33.92M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
17.26MCNY
2.56M · vs all stocks (USD)
Updated Aug 19, 2026
Payout Ratio
0.00%
Updated Aug 19, 2026
Minority Interest (Equity)
21.46KCNYFY2025 · Dec 31, 2025
Revenue
855.89MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
662.78MCNYFY2025 · Dec 31, 2025
Gross Profit
193.11MCNYFY2025 · Dec 31, 2025
Operating Income
-127.83MCNY
-18.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-108.41MCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.11MCNYFY2025 · Dec 31, 2025
Net Income
-109.52MCNYFY2025 · Dec 31, 2025
EBIT
-106.13MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-43.66MCNYFY2025 · Dec 31, 2025
Research & Development
197.97MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
60.37MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
1.92MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
9.47MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.28MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3221CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3221CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
340.00MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
340.00MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-109.52MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
644.00CNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-175.44MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-292.66MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
505.44MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-109.52MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
3.35MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-171.53MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
102.25MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-117.22MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-149.43MCNYFY2025 · Dec 31, 2025
Sale of Investments
302.97MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
36.32MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
49.90MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-84.40MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.73MCNYFY2025 · Dec 31, 2025
Other Financing Charges
18.65MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-17.58MCNYFY2025 · Dec 31, 2025
Shares Outstanding
340.05MSharesUpdated Aug 19, 2026
Float Shares
293.41MSharesUpdated Aug 19, 2026
% Held by Insiders
12.46%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
2.33%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
439.45MCNY
65.17M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
1.29CNYUpdated Aug 19, 2026
Total Debt (MRQ)
213.33MCNY
31.64M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.1337x
Updated Aug 19, 2026
Current Ratio (MRQ)
1.91x
Updated Aug 19, 2026
Book Value per Share (MRQ)
4.69CNYUpdated Aug 19, 2026
Total Assets
2.41BCNY
356.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.35BCNYFY2025 · Dec 31, 2025
Total Liabilities
670.28MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
28.91MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
641.37MCNYFY2025 · Dec 31, 2025
Cash
255.44MCNYFY2025 · Dec 31, 2025
Cash Equivalents
273.64MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
529.08MCNYFY2025 · Dec 31, 2025
Accounts Receivable
235.40MCNYFY2025 · Dec 31, 2025
Inventory
240.37MCNYFY2025 · Dec 31, 2025
Accounts Payable
374.67MCNYFY2025 · Dec 31, 2025
Short-term Debt
34.89MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
83.66KCNYFY2025 · Dec 31, 2025
Long-term Debt
16.08MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
340.05MCNYFY2025 · Dec 31, 2025
Retained Earnings
-469.16MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.73BCNY
257.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
21.55MCNYFY2025 · Dec 31, 2025
52-Week Low
12.92CNYUpdated Aug 19, 2026
52-Week High
48.51CNYUpdated Aug 19, 2026
52-Week Change
-67.18%
vs all stocks
Updated Aug 19, 2026
Beta
0.2570x
vs all stocks
Updated Aug 19, 2026
50-Day MA
17.57CNYUpdated Aug 19, 2026
200-Day MA
23.38CNYUpdated Aug 19, 2026
Avg 10-Day Volume
13.73MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
17.08MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-0.4900CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.49Receivables vs revenue divergence: 3.01
Financial Health
Altman Z-Score 4.97: safe zoneNotable
Altman Z-Score: 4.97
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.